ABCDx Secures U.S. Patent and Publishes Paediatric TBI (Traumatic Brain Injury) Breakthrough, Expanding IP and Market Leadership

ABCDx SA, a leader in biomarker-based diagnostics for acute brain disorders, today announced two strategic milestones strengthening its competitive position and licensing opportunities:

• The USPTO has granted ABCDx a patent protecting its novel H-FABP + GFAP diagnostic method for adult traumatic brain injury (TBI).

• The company’s paediatric TBI biomarker study has been published in the Journal of Neurotrauma, confirming the diagnostic value of IL-6–based biomarker panels to safely reduce CT scans and hospital stays in children.

Exhibitor Data Sheet